|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/67 | (2006.01) |
| C12N 15/67 | (2013.01) | ||
| C12N 15/85 | (2006.01) | ||
| A61K2039/53 | (2013.01) | ||
| A61K 31/7105 | (2006.01) | ||
| A61K2039/54 | (2013.01) | ||
| A61K 31/711 | (2006.01) | ||
| C12N2760/16134 | (2013.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 4023755 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21209125.0 |
| Date of filing the European patent application | 2015-12-11 | |
| (97) | Date of publication of the European application | 2022-07-06 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| PCT/EP2014/003334 | 2014-12-12 | WO |
| (72) |
Theß, Andreas , DE
Schlake, Thomas , DE
Grund, Stefanie , DE
|
| (73) |
CureVac SE ,
Friedrich-Miescher-Straße 15, 72076 Tübingen,
DE
|
| (54) | ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN EXPRESSION |
| ARTIFICIAL NUCLEIC ACID MOLECULES FOR IMPROVED PROTEIN EXPRESSION |